Published: 2018-12-08

Articles

BUILDING A STRUCTURED MONITORING AND EVALUATING SYSTEM OF POSTMARKETING DRUG USE IN SHANGHAI

Wenmin Du, Mitchell Levine, Longxing Wang, Chengdong Yi, Hongmin Wang, Xiaoyu Wang, Hongjuan Xie Xie, Jianglong Xu, Huilin Jin, Tongchun Wang, Gang Huang, Ye Wu
Abstract 105 | PDF Downloads 70

COUNSELING REGARDING PREGNANCY- RELATED DRUG EXPOSURES BY FAMILY PHYSICIANS IN ONTARIO

Jodi Goodwin, Scott Rieder, Michael J Rieder, Doreen Matsui
Abstract 78 | PDF Downloads 48

45 YEARS LATER… WHERE DO WE STAND?

Mercédes Benegbi
Abstract 95 | PDF Downloads 51

PAEDIATRIC ADVERSE DRUG REACTION REPORTING: UNDERSTANDING AND FUTURE DIRECTIONS

Bruce C Carleton, M Anne Smith, Michaela N Gelin, Susan C Heathcote
Abstract 337 | PDF Downloads 112

DRUGS IN PREGNANCY: ACKNOWLEDGING CHALLENGES - FINDING SOLUTIONS

Gideon Koren, Stuart MacLeod, Donald Davis
Abstract 355 | PDF Downloads 63

DRUGS USED IN PREGNANCY: THE REGULATORY PROCESS

Anne Tomalin
Abstract 91 | PDF Downloads 99

THE WAY WOMEN PERCEIVE TERATOGENIC RISK

Gideon Koren
Abstract 408 | PDF Downloads 137

INACTIVE PHARMACEUTICAL INGREDIENTS: IMPLICATIONS FOR PREGNANCY

Yaron Finkelstein, Massoud Rezvani, Facundo Garcia-Bournissen, Laila Nurmohamed, Gideon Koren
Abstract 755 | PDF Downloads 404

CHALLENGES IN DRUG USE NEAR TERM AND DURING DELIVERY

Dan Farine
Abstract 88 | PDF Downloads 49

COLLECTION AND ANALYSIS OF DRUG SAFETY DATA IN PREGNANCY

Myla Moretti
Abstract 71 | PDF Downloads 48

COLLECTION AND ANALYSIS OF DRUG SAFETY DATA IN PREGNANCY

Myla Moretti
Abstract 76 | PDF Downloads 39

CRITICAL APPRAISAL ROUNDS: A NEW TRAINING MODEL FOR CLINICAL PHARMACOLOGISTS

Gideon Koren, Irena Nulman
Abstract 315 | PDF Downloads 54

USE OF CELECOXIB IMMEDIATELY POST MARKETING IN CANADA: ACUTE OR CHRONIC PAI N?

Anita L Kozyrskyj, Colette Raymond, Amber Racher Racher
Abstract 84 | PDF Downloads 55